Interleukin-12 inducer and medical composition
OwnerAkikuni Yagitainventor
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising activated hemicellulose (AHCC), a method for inducing IL-12 in a living body having tumor cells by administering the composition, and a method for treating cancer by administering the composition are provided.
Claims17
A pharmaceutical composition comprising activated hemicellulose as an active ingredient in an amount effective to induce interleukin-12 and a pharmaceutically acceptable carrier.
A method for inducing interleukin-12 in vivo, comprising administering a pharmaceutical composition containing activated hemicellulose as an active ingredient and a pharmaceutically acceptable carrier.
A method for treating cancer, comprising administering a pharmaceutical composition containing activated hemicellulose (AHCC) as an active ingredient and a pharmaceutically acceptable carrier by a single or simultaneous use in an amount which can induce interleukin-12 in vivo.
Dependencies are inferred from the claim text.